A detailed history of First Horizon Advisors, Inc. transactions in Twist Bioscience Corp stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 705 shares of TWST stock, worth $34,509. This represents 0.0% of its overall portfolio holdings.

Number of Shares
705
Previous 643 9.64%
Holding current value
$34,509
Previous $23,000 4.35%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 26, 2024

BUY
$32.28 - $41.5 $2,001 - $2,573
62 Added 9.64%
705 $24,000
Q4 2023

Feb 06, 2024

SELL
$15.08 - $38.61 $196 - $501
-13 Reduced 1.98%
643 $23,000
Q3 2023

Oct 27, 2023

SELL
$18.62 - $26.57 $6,889 - $9,830
-370 Reduced 36.06%
656 $13,000
Q2 2023

Aug 03, 2023

SELL
$11.49 - $20.46 $1,252 - $2,230
-109 Reduced 9.6%
1,026 $20,000
Q1 2023

May 15, 2023

SELL
$14.6 - $30.9 $584 - $1,236
-40 Reduced 3.4%
1,135 $17,000
Q4 2022

Feb 10, 2023

BUY
$21.92 - $39.37 $25,756 - $46,259
1,175 New
1,175 $27,000

Others Institutions Holding TWST

About Twist Bioscience Corp


  • Ticker TWST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 56,363,500
  • Market Cap $2.76B
  • Description
  • Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...
More about TWST
Track This Portfolio

Track First Horizon Advisors, Inc. Portfolio

Follow First Horizon Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Advisors, Inc. with notifications on news.